Vaccine Research Center Seminar Series, Winter 2012:
- Jan 24 Jeff Cohen NIAID, NIH - Herpes simplex virus 2 vaccines: Beyond glycoprotein
- Jan 31 Chris Walker Ohio State University - Immune control of persistent hepatitis C virus infection
- Feb 7 Fred Alt Harvard University - High throughput analysis of mechanisms that influence chromosomal rearrangements and translocations in lymphocytes
- Feb 14 Jim Crowe Vanderbilt University - Genetic and structural complexity of human antibody repertoires
- Feb 21 Ed Mocarski Emory University - Caspase-8 and RIP3-dependent death pathways: lessons from Cytomegalovirus
- Feb 28 Pat Earl NIAID, NIH - Small animal models of lethal injection for studying monkeypox virus
- Mar 6 Robin Shattock St. George’s Hosp., Univ. London - Vaginal antibodies as a determinant of HIV susceptibility
- Mar 13 Charles Mackay Monash University - Dietary and microbiome influences on gut health and inflammatory disease
- Apr 10 Rick Blumberg Brigham and Women’s Hospital - The immunological functions of the (not so) neonatal FcR for IgG
- Apr 17 Gepi Pantaleo University of Lausanne - T-cell immunity in HIV infection and vaccine development
For more information, please see http://vrc.nih.gov/cgi-shl/vrc/seminars.cfm
Featured Reports
